Engineering Circulating Tumor Cells as Novel Cancer Theranostics
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 10 (17) , 7925-7937
Abstract
New ways to target and treat metastatic disease are urgently needed. Tumor “self-homing” describes the recruitment of circulating tumor cells (CTCs) back to a previously excised primary tumor location, contributing to tumor recurrence, as well as their migration to established metastatic lesions. Recently, self-homing CTCs have been exploited as delivery vehicles for anti-cancer therapeutics in preclinical primary tumor models. However, the ability of CTCs to self-home and treat metastatic disease is largely unknown.Keywords
This publication has 73 references indexed in Scilit:
- In Vitro and In Vivo Effect of 5-FC Combined Gene Therapy with TNF-α and CD Suicide Gene on Human Laryngeal Carcinoma Cell Line Hep-2PLOS ONE, 2013
- Monoclonal antibodies: versatile platforms for cancer immunotherapyNature Reviews Immunology, 2010
- Mesenchymal stem cell therapy: Two steps forward, one step backTrends in Molecular Medicine, 2010
- Tumor Self-Seeding by Circulating Cancer CellsCell, 2009
- Prodrug cancer gene therapyCancer Letters, 2008
- Biodegradable nanoparticles for cytosolic delivery of therapeutics☆Advanced Drug Delivery Reviews, 2007
- Stem Cells: A Revolution in Therapeutics—Recent Advances in Stem Cell Biology and Their Therapeutic Applications in Regenerative Medicine and Cancer TherapiesClinical Pharmacology & Therapeutics, 2007
- Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic–ischemic brain injuryExperimental Neurology, 2006
- Occurrence of leukaemia following gene therapy of X-linked SCIDNature Reviews Cancer, 2003
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002